cis-(Carbonato-j 2 O,O 0 0 0 )(rac-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-j 4 N)chromium(III) bromide monohydrate
(meso-5,7,7,12,14,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N)nickel(II) [N,N-o-phenylenebis(oxamato)-κ4O,N,N′,O′]cuprate(II) dihydrate
✍ Scribed by Gao, En-Qing
- Publisher
- International Union of Crystallography
- Year
- 2004
- Tongue
- English
- Weight
- 305 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Crystallization of [Cd(S-thpc12)](ClO 4 ) 2 ÁH 2 O {S-thpc12 is 1,4,7,10-tetrakis[(S)-2-hydroxypropyl]-1,4,7,10-tetraazacyclo-dodecane} in the presence of sodium salicylate (sodium o-hydroxybenzoate) forms a receptor complex, namely the title compound, [Cd(C 20 H 44 N 4 O 4 )(C 7 H 5 O 3 )]ClO 4 Á0.
A new heterotrinuclear macrocyclic complex: bis (ldiethyl 5,6,7,8,15,16-hexahydro-6,7-dioxo-5,8,14,17tetraazadibenzo[a,g]cyclotetradecine-13,18dicarboxylato)-1j 4 N:2j 2 O 6 ,O 7 ;2jO 6 ,O 7 :3j 4 Ndimethanoldinickel(II)zinc(II) bis(perchlorate)
Single-crystal X-ray study T = 150 K Mean '(C±C) = 0.006 A Ê Disorder in solvent or counterion R factor = 0.069 wR factor = 0.205 Data-to-parameter ratio = 14.9 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.